Pande Atul — SEC Form 4 filings
SEC reporting owner CIK 1643071. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-18 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 19,750 shares, $645,835 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 7,750 shares @ $28.54 ($221,185) in Immunovant, Inc., filed 2024-12-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Director | 9 | — | 6 legs · 19,750 sh · $645,835 | 16 |
| Karuna Therapeutics, Inc. (KRTX) | Director | 1 | — | — | 5 |
Form 4 filings — Pande Atul
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 1,500 @ $8.43 · Sale (S): 1,500 @ $43.27 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2026-07-24 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 1,500 @ $8.43 · Sale (S): 1,500 @ $39.80 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 1,500 @ $8.43 · Sale (S): 1,500 @ $38.01 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 1,500 @ $8.43 · Sale (S): 1,500 @ $34.02 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 6,000 @ $8.43 · Sale (S): 6,000 @ $32 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-04-09 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 13,880 @ $0 · Grant/award (A): 7,061 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 16,188 @ $0 · Grant/award (A): 7,600 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 7,750 @ $28.54 | EDGAR |
| 2024-04-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 11,255 @ $0 · Grant/award (A): 4,690 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | Karuna Therapeutics, Inc. (KRTX) | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 12,500 (derivative) @ $232.41 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1643071 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →